Financialbuzz: Wearable Technology Devices to Focus More on Health

Tuesday, November 8, 2016 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, November 8, 2016 /PRNewswire/ -- - As technology becomes more advanced

and costs of production falling, wearable devices become more mainstream. While the fitness trackers and wearable cameras were the most popular wearable devices, a stronger emphasis on health and a bigger demand for home care are expected drive up demand
for medical wearables. According to a recent research by Global Market Insights, a market research and management consulting company, the wearable devices market size is anticipated to exceed USD 12 billion by 2023, which represents growth of about 24% CAGR from 2016 to 2023. Biotricity Inc. (OTC: BTCY), Apple Inc. (NASDAQ: AAPL), Fitbit Inc. (NYSE: FIT), GoPro Inc. (NASDAQ: GPRO), Garmin Ltd. (NASDAQ: GRMN).

A rising demand for sophisticated devices, combined with innovative features is what expected to drive demand. Also according to the research electronic wearable medical devices that offer monitoring solutions on numerous health parameters such as glucose, blood sugar, chronic diseases, namely diabetes and heart diseases are expected to be a sector with major developments.

Biotricity Inc. (OTCQB: BTCY) is a medical technology company committed to improving healthcare by developing solutions that aid chronic disease prevention and management. The company's flagship wearable medical device, Bioflux, is an ECG monitoring system that will be prescribed by physicians to diagnose and remotely monitor cardiac patients. 

Biotricity Inc. recently announced that Bioflux received the necessary 501k clearance from the Food & Drug Administration (FDA). Soon after the company announced that it has appointed Dr. Rony Shimony to its Board of Advisors (BOA). Shimony is an internationally recognized clinical cardiologist who brings to the company over twenty-five years of experience in cardiac patient care and related technology.

President and CEO of Biotricity Inc. Waqaas Al-Siddiq, "We look forward to leveraging Dr. Shimony's clinical and diagnostic expertise to help drive the adoption of our next-generation medical-grade wearables in mainstream healthcare practices… As heart disease remains the #1 killer globally, representing 31 percent of all deaths worldwide, we are thrilled to have Dr. Shimony bring his expertise to our advisory board where he will collaborate with other talented and accomplished members to help drive our strategic vision of evolving the healthcare industry."

Apple Inc. (NASDAQ: AAPL) has given hints that the company will soon enter into a rewarding business such as healthcare by next year. Tim Cook is looking for life further than the iWatch. In Taiwan's Economic Daily News, it said that Apple will celebrate its tenth year anniversary of the iPhone with a wearable device that will "accurately collect users' personal daily life including heart rate, pulse, blood sugar changes and other information." A report from Market Data Forecast suggests the medical devices market value will reach $11.2 billion by 2020.

Apple isn't the only company keeping an eye on the healthcare industry. Sales of more traditional wearable devices ranging from fitness trackers to wearable camera, for example Fitbit Inc. (NYSE: FIT) along with GoPro Inc. (NASDAQ: GPRO) are declining. Currently, Fitbit has closely affiliated themselves with researchers carrying out clinical trials. Alongside with research platform Fitabase, they have been shifting the way medical research is being conducted with well-known Universities such as Johns Hopkins and the Texas MD Anderson Cancer Center among those who have chosen to tap into data from Fitbit users around the world. "Historically, measuring participants' activity, sleep, and heart rate data over significant periods of time has been logistically difficult to collect and costly to measure," said Aaron Coleman, CEO of Fitabase.

There's no shortage of fitness trackers in our current market. Garmin Ltd. (NASDAQ: GRMN) launched Vivosmart HR+ with substantial upgrades on the original. The fitness wearable device includes a heart rate sensor with built-in GPS, meaning it's a runner's best friend. Like any normal GPS watch, the HR+ tracks pace, distance, calories and time. It could only display one metric at a time. Other notable features consist of smart notifications and daily activity tracking.

Subscribe Now! Watch us report from NYSE

For "The Latest Buzz in Financial News", SIGN UP & Visit:

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. has signed a four-month financial news dissemination and pr services agreement for ten thousand dollars directly from the biotricity inc. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. agreed to a four-month financial news dissemination and pr services agreement for ten thousand restricted shares and twenty thousand warrants directly from biotricity inc. does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information: Media Contact: Danny A, , +1-877-601-1879 Url:



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store